Biggest News Aggregation in the World
📰 Granted News

Page 106 - Granted News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Granted. Real-time updates on events, politics, business and more.

Legend Biotech: CARVYKTI (ciltacabtagene autoleucel) Granted Conditional Approval by the European Commission for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

CARVYKTI is Legend Biotech's first European Commission-approved product The approval is based on the pivotal phase 1b/2 CARTITUDE-1 study, which demonstrated an overall response rate (ORR)
New Jersey United States Ciltacabtagene Autoleucel Joanne Choi Hermann Einsele Ying Huang

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Global Battery Metals Ltd: Global Battery Metals Granted Four New Mineral Leases to Expand its Michigan Nickel-Copper Project

Plans Underway for Electromagnetic Surveying Vancouver, British Columbia--(Newsfile Corp. - May 24, 2022) - Global Battery Metals Ltd. (TSXV: GBML) (OTCQB: REZZF) (FSE: REZ) (the "Company" or "GBML")
United States United Kingdom State Of Michigan British Columbia Michael Murphy North West Leinster

OptraSCAN's Artificial Intelligence-equipped digital pathology scanner OS-SiA granted US Patent for scanning, indexing and analyzing of the tissue area at the same time

San Jose (California) [US], May 24 (ANI/PRNewswire): OptraSCAN, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Office.
United States United Kingdom Abhi Gholap Trademark Office University Of British Columbia San Jose

ENB Therapeutics, Inc.: ENB Therapeutics Announces Orphan Drug Designation Granted by FDA for ENB-003 for the Treatment of Pancreatic Cancer

ENB-003 is a first in class small molecule therapeutic selectively targeting the ETB receptor - a novel immune checkpointNEW YORK, NY / ACCESSWIRE / May 24, 2022 / ENB Therapeutics, Inc., a clinical stage
United States Kostenloser Wertpapierhandel Sumayah Jamal Therapeutics Inc Drug Administration Orphan Drug Designation

OptraSCAN Inc.: OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time

SAN JOSE, Calif., May 24, 2022 /PRNewswire/ -- OptraSCAN, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent
United States United Kingdom Kostenloser Wertpapierhandel Abhi Gholap Prnewswire Optra Optrascan Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science